SCHEMBL7837577

SCHEMBL7837577

FCC1=CCCc2ccccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.46
CES1 P23141 1/20 0.39
MPO P05164 1/20 0.38
G6PC1 P35575 1/20 0.36
CYP2A6 P11509 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
HTR6 P50406 2/20 0.35
SLC6A2 P23975 2/20 0.35
PARP1 P09874 2/20 0.35
SLC22A1 O15245 1/20 0.35
CACNA1F O60840 1/20 0.35
NTRK1 P04629 1/20 0.35
CYP1A2 P05177 1/20 0.35
ADRB2 P07550 1/20 0.35
RET P07949 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
ADRB1 P08588 1/20 0.35
HTR1A P08908 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11503302 0.80 MPO (0.57) SIGMAR1CES1MPOG6PC1CYP2A6
SCHEMBL6825529 0.80 SIGMAR1 (0.46) SIGMAR1CES1MPOG6PC1CYP2A6
SCHEMBL29446311 0.80 SIGMAR1 (0.46) SIGMAR1CES1MPOG6PC1CYP2A6
SCHEMBL9379776 0.80 SIGMAR1 (0.46) SIGMAR1CES1MPOG6PC1CYP2A6
SCHEMBL5489164 0.80 SIGMAR1 (0.46) SIGMAR1CES1MPOG6PC1CYP2A6
SCHEMBL28424372 0.80 SIGMAR1 (0.46) SIGMAR1CES1MPOG6PC1CYP2A6
Hydrochloric Acid SCHEMBL10649574 0.78 SIGMAR1 (0.44) SIGMAR1CES1MPOG6PC1CYP2A6
Hydrochloric Acid SCHEMBL15053825 0.78 SIGMAR1 (0.44) SIGMAR1CES1MPOG6PC1CYP2A6
SCHEMBL14290594 0.78 SIGMAR1 (0.55) SIGMAR1
SCHEMBL10395522 0.77 SIGMAR1 (0.47) SIGMAR1CES1MPOG6PC1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465880-B1 5-SULPHANYL-4H-1,2,4-TRIAZOLE DERIVATIVES AND THEIR USE TO TREAT DISORDERS ASSOCIATED WITH SOMATOSTATINE IPSEN PHARMA (FR) 2009-08-05 EP disclosed
EP-1123285-A1 SUBSTITUTED BENZOPYRAN ANALOGS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 2001-08-16 EP disclosed
WO-2000023433-A1 SUBSTITUTED BENZOPYRAN ANALOGS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 2000-04-27 WO disclosed